abstract |
The invention provides methods of preventing and treating graft-versus-host-disease, such as those arising from transplant therapy, by selective depletion of hematopoietic cells through the use of antibodies, antibody fragmnets, and antibody-drug conjugates that specifically bind CD252. compositions and methods described herein can be used to treat a variety of pathologies, including stem cell disorders and other blood conditions. |